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1. Introduction 
  The bilayer tablet is a concept which is composed of different layers. The system allows the incorporation of more 
than one drug into the dosage form. Formulation of layers from different polymers allows manipulation over more than one 
rate-controlling polymer, thus enabling different types of drug delivery of one or more drugs.[1] Floating Bilayer drug 
delivery system is combined principle of bilayer tablet as well as floating mechanism. Floating Bilayer tablet is suitable for 
sequential release of two drugs in combination, separate two incompatible substances and also for sustained release tablet in 
which one layer is immediate release as initial dose and second layer is maintenance dose.[3] Floating drug delivery 
systems have a bulk density less than gastric fluids and so remain buoyant in the stomach without affecting the gastric 
emptying rate for a prolonged period of time. [2] While the system is floating on the gastric contents, the drug is released 
slowly at the desired rate from the system.    
              Bioavailability of poorly water‐soluble hydrophobic drugs is limited by their solubility and dissolution rate.[5] The 
solid dispersion technique shows promising results in improving solubility, wettability, dissolution rate of drug and 
subsequently its bioavailability.[6] The mechanism by which solid dispersion enhances the solubility and dissolution 
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involves particle size reduction to fine form or molecular level, conversion of crystalline form to amorphous form and by 
enhancing wettability.  
Hypertension 
According to WHO, state in which systolic pressure is 150mm Hg or more and diastolic pressure is 95mm Hg or 
more. Nifedipine decreases arterial smooth muscle contractility and subsequent vasoconstriction by inhibiting the influx of 
calcium ions through L-type calcium channels. Nifedipine reduces the peripheral arterial vascular resistance and releases 
coronary artery spasms. Thus it has hypotensive and antianginal properties. The vasodilatory effects of Nifedipine result in 
an overall decrease in blood pressure. The main objective of developing this system is to prepare sustain release 
composition which release Nifedipine over prolonged period of time.[7] 
 
2. Material and method 
Nifedipine gifted by Pell Tech Health Care Pvt. Ltd., Malad (W) Mumbai. HPMC K 100M, HPMC K 15M, 
NaHCO3 were gifted by SD Fine Chem. Croscarmellose Sodium, crospovidone, avicel PH102 and starch were purchased 
from Visual Chem, Mumbai. Sodium starch glycolate, Carbopol 934P, Citric acid, Magnesium stearate were purchased 
from Research-Lab Fine Chem Industries.  Avicel PH102 and Starch were purchased from Hilab Chemicals.  
 
Equipments 
Table No.1:  List of Equipments used in this study 
 
Sr.  No. Equipment Mfg. By 
1. Electronic weighing balance Schimadzu, Japan 
2. Tablet Compression Machine Emtech 
3. Hot air oven Bio Techno Lab. 
4. Dissolution apparatus Electrolab 
5. U.V. Spectrophotometer Shimadzu 1800 
6. FTIR Spectrophotometer Perkin Elmer Spectrum 65 
7. Hardness tester Monsanto 
8. Disintegration Apparatus Shreeji 
9. Friability Apparatus  Roche Friablator 
10. Stability Chamber Bio techno lab 
11. Differential Scanning Calorimeter Miller Star sw 9.01 
12. X-rayDiffraction Spectrometer. Siemens,Germany D-5000 
 
2. Formulation Development 
2.1 Preparation Surface Solid Dispersion of Nifedipine:- 
2.2 Preparation of Bilayer Floating Tablet:- 
2.1 Preparation Surface Solid Dispersion of Nifedipine:-  
Before preparation of surface solid dispersion there was need to select optimized conditions for preparation of 
surface solid dispersion. The selected drug was light sensitive. The light of wavelength greater than 420 nm was only 
suitable for stability of drug.
[8]
 Another way was to formulate dosage form in dark background.  The formulation was 
prepared under the light of wavelength greater than 420 nm i.e. in compact fluorescent lamp having wavelength 400-
700nm. 
2.1.1 Procedure:  
Required amount of Nifedipine was dissolved in 20 ml of Ethanol. Accurately weighed carrier corresponding to 
different drug: carrier ratio by weight was dispersed in drug solution. Kept it closed for one hour. Then the solvent was 
allowed to evaporate on water bath under occasional stirring at temperature of 40-42ºC in a protected environmental 
condition. The dried mass was pulverized and was passed through a #100 mesh sieve. The powder was subsequently dried 
at 40ºC for 3 hours in a tray drier. The powder was stored in desiccators for further studies.[9] 
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Table 2: Coding formulations for SSD of Nifedipine 
Drug Nifedipine Nifedipine Nifedipine 
Carrier SSG CCNa CP 
Code SSD-S1 SSD-C1 SSD-P1 
Code SSD-S2 SSD-C2 SSD-P2 
Code SSD-S3 SSD-C3 SSD-P3 
Code SSD-S4 SSD-C4 SSD-P4 
Code SSD-S5 SSD-C5 SSD-P5 
Drug : Carrier ratio 1:1 1:1 1:1 
Drug : Carrier ratio 1:2 1:2 1:2 
Drug : Carrier ratio 1:3 1:3 1:3 
Drug : Carrier ratio 1:4 1:4 1:4 
Drug : Carrier ratio 1:5 1:5 1:5 
       
2.3 Preparation of Bilayer Floating Tablet         
Tablets were prepared by direct compression technology using 8 stations tablet punch machine. Bilayer floating 
tablets were prepared in two stages. Both the layers were prepared separately. Bilayer tablets were prepared by double 
compression technique. First, previously weighed quantity of floating sustained release layer was fed to die cavity as the 
second layer and compressed very slightly to get uniform layer, then weighed quantity of immediate release layer blend was 
fed in to the die cavity as the first layer and compressed finally to get bilayer tablet. By this method, the immediate release 
layer was compressed once, so there is fast disintegration and avoidance of the double compression. The compositions 
details of Bilayer floating tablets are given in following table.  
2.3.1 Dose calculation for bilayer tablet 
Dose Calculation: For sustained drug release up to 12 hr, the immediate dose of drug was calculated from total dose of 
Nifedipine sustained release tablet, which is 20 mg. Dt = Dose (1 + 0.693 × t/t 1/2) 
Where,  
Dt = Total dose; Dose = Immediate release dose; t = Total time period for which sustained release is required 
t1/2 = Half-life of drug ( Nifedipine ) 2hr     
For example, Nifedipine (20mg) = Dose [1+ (0.693 ×12)/2] 
                                Dose = 3.87 mg Nifedipine. 
According to dose calculation, IR dose of drug is 3.87mg for the preparation of bilayer tablets.  The maintenance 
dose is 16.13mg. Equivalent dose of Nifedipine is taken from surface solid dispersion and added in both layers to form 
bilayer tablet formulation.[10]  
Table No.3: Composition of Bilayer Floating Tablet 
Sr No. 
Ingredients Batch code 
Immediate Release Layer IR IR IR IR IR IR IR IR IR 
1 SD of Nifedipine 3.87 3.87 3.87 3.87 3.87 3.87 3.87 3.87 3.87 
2 Starch 5 5 5 5 5 5 5 5 5 
3 Mg. Stearate 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
4 Avicel pH102  78.78 78.78 78.78 78.78 78.78 78.78 78.78 78.78 78.78 
Sustain Release Layer SR1 SR2 SR3 SR4 SR5 SR6 SR7 SR8 SR9 
1 SD of Nifedipine 16.13 16.13 16.13 16.13 16.13 16.13 16.13 16.13 16.13 
2 HPMC K100M 100 80 60 100 80 60 100 80 60 
3 HPMC K15M 10 20 30 20 30 10 30 10 20 
4 Carbopol 934P 10 10 10 10 10 10 10 10 10 
5 Sod. bicarbonate 30 30 30 30 30 30 30 30 30 
6 Citric acid 15 15 15 15 15 15 15 15 15 
7 Mg. Stearate 4 4 4 4 4 4 4 4 4 
8 Talc 2 2 2 2 2 2 2 2 2 
9 Avicel pH102 23.18 33.18 43.18 13.18 23.18 63.18 3.18 43.18 53.18 
10 Ferric oxide red 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 
*All quantities in „mg‟ ;*Total Weight of Bilayer Floating tablet: 360mg.;* SD: Solid Dispersion.; *Mg. stearate: Magnesium stearate.; 
*HPMC: Hydroxy P Propyl Methyl Cellulose.; *Sod.: Sodium. 
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3. Evaluation 
3.1 Pre-compression parameter:[11]
 
3.1.1 Angle of repose: In this method weighed 10 gm of bulk powder, passed it through sieve no 40 mesh size .then 
allowed to flow under gravity though funnel and angle of incline of the formed. That is produced is assayed by measuring 
the height (h) and having a fixed base i.e. radius (r). 
             
 Angle of Repose θ = tan –1 h/r 
 
3.1.2 Bulk Density: It is the ratio of total mass of powder (m) to the bulk volume of powder.                                                  
Dt=m/Vo                                                                                                                                                                               
3.1.3 Tapped Density: It is the ratio of total mass of powder (m) to the tapped volume (Vi) of powder.                                                                                       
Dt = m/Vi 
3.1.4 Compressibility index: It is determined by taking tapped density and bulk density. Which has been put in the formula 
given below and determined compressibility index. 
Compressibility Index= Tapped density – bulk density / tapped density x 100 
3.1.5 Hausner’s Ratio:-It is determined by taking Tapped density and it divided by Bulk density by using following 
formula: Hausner’s Ratio= Tapped density / Bulk density 
3.2 Evaluation Parameter of Bilayer Floating Tablets:  
Prepared Floating Bilayer tablets were evaluated for compression parameters such as Hardness, Weight variation, 
Friability, Drug content, % Drug Release, Buoyancy lag time, Floating time, etc. 
3.2.1 Hardness:- Tablet hardness is also known as tablet crushing strength & was determined by Monsanto hardness tester.. 
3.2.2 Friability:- Friability test is performed to assess the effect of abrasions and shock that may often cause tablet to chip, 
cap or break. Roche Friabilator was used for the purpose. 
 
 % F= {Wo – W / Wo)×100 
 
Where, % F= Friability in percentage; Wo= Initial weight of tablet; W=   Final weight after revolution  
3.2.3 Drug content:- The Nifedipine content in tablets was determined by powdering 10 tablets in each batch. Powder 
equivalent to 100 mg of Nifedipine was dissolved in 0.1 N HCl. 1 ml of filtrate was further diluted to 100 ml with 0.1 N 
HCl and it was determined by U.V. spectroscopy at 341.2 nm. 
3.2.4 Weight variation: 10 tablets of each of formulation were weighed individually using an electronic balance. The 
average weight was calculated and individual tablet weight was compared with average value and the deviation was 
recorded. 
3.2.5 Thickness: The thickness of tablets was determined using Digital Vernier Caliper, (Mitutoyo, Japan). It is expressed 
in mm.
 
 
3.2.6 Disintegration Time: Six tablets were selected randomly from each batch for the disintegration test. Disintegration 
test was performed in simulated gastric fluid using disintegration tester. Disintegration time (DT) was measured for 
immediate release layer.  
3.2.7 Determination of Buoyancy lag time: The buoyancy lag is the time required for tablet to rise towards surface & 
float. The buoyancy of tablets was studied at 37±0.5ºc in 900ml of simulated gastric fluid. The buoyancy lag time was 
measured by using stop watch and total floating time was observed visually.  
3.2.8 Floating time: Floating time was determined by using USP dissolution apparatus-II at 50 rpm using 900ml of 0.1N 
HCl and temperature was maintained at 37±0.5ºC, throughout the study. The duration of floating (floating time) is the time 
the tablet floats in the dissolution medium (including floating lag time, which is the time required for the tablet to rise to the 
surface) is measured by visual observation. 
3.2.9 Swelling Index:
 
Swelling study was performed for the floating sustained release layer tablets. The accurately weighed 
tablets were placed in USP dissolution apparatus II containing 900ml of  0.1N HCl maintained at 37±2ºC and allowed to 
swell up to constant weight. The tablets were removed, blotted with filter paper, and changes in weight were measured. The 
experiments were carried out in triplicate. The degree of swelling (Swelling index) was then calculated from the formula. 
 
Where, W o is the initial weight of tablet and Wg is the weight of tablet at equilibrium swelling in the medium. 
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3.2.10 In-vitro drug release study: In-vitro dissolution studies of floating tablets of Nifedipine were carried out in USP 
dissolution test apparatus-II, employing a paddle type apparatus at 50 rpm using 900ml of 0.1N HCl as dissolution medium 
at 37±0.5ºC. One tablet was used in each test. At predetermined time intervals 5ml of the samples were withdrawn by 
means of a syringe. The volume withdrawn at each interval was replaced with same quantity of fresh dissolution medium 
maintained at 37±0.5ºC. The withdrawn samples were filtered through membrane filter 0.45μm & analyzed by using UV 
spectrophotometer at λ max 338.2nm. This test was performed on 9 batches of bilayer tablets.[12]  
3.2.11 FITR study of optimized Bilayer Floating Tablet:-About 1mg of sample was mixed thoroughly with 100 mg 
potassium bromide IR powder and compacted under vacuum at a pressure of about 12 psi for 3 minutes. The resultant disc 
was mounted in a suitable holder in Perkin Elmer IR spectrophotometer USA and the IR spectrum was recorded from 4000 
cm-1 to 400 cm-1 in a scan time of 12 minutes. An FTIR spectrum of final optimized formulation was obtained.  The 
resultant spectra were compared for any spectral changes. 
3.2.12 Differential Scanning Calorimetry study for optimized Formulation:- Final optimized formulation was assessed 
by carrying out thermal analysis “Miller Star sw 9.01” differential scanning calorimeter. The sample (1-2mg) was carefully 
transferred & heated in a crimped aluminum pan for accurate result. The sample was heated from 30-300ºC at the rate of 
10ºC /min.  Then the inert atmosphere was maintained by purging Nitrogen gas throughout the experiment at the rate of 
40ml/min. 
3.2.13 Stability Studies and Storage Condition: To check the effect of environmental condition or storage conditions on 
formulation. Final formulation was kept in environmental stability chamber for accelerated stability condition at 40
o
C±2 ̊C 
temperature and 75 ± 5 % relative humidity for a period one month. The samples were withdrawn after 10 days, 20 days 
and 30 days intervals and evaluated for physical parameters, drug content, in-vitro drug release and floating behavior etc. 
3.2.14 Optimization of Bilayer Floating Tablet: Optimization of formulation variables for preparation of Bilayer floating 
Tablet of Nifedipine by using 3
2
 Full factorial designs. To study the effect of variables, we applied the 3
2 
factorial designs. 
The amount of HPMC  K 100M (X1) and HPMC K15M (X2) were kept as an independent variables and Hardness of 
tablet(Y1), % drug release (Y2) & percent swelling (Y3)  were selected as dependent variables. 
 
4. Result and Discussion 
Table 4: Result of Bulk density, Tapped density, % Compressibility, Hausner’s ratio & Angle of repose of surface 
solid dispersion of Nifedipine *All values are expressed as Mean ± SD, n 
 
Batch Code 
Parameters 
Bulk Density 
(gm/cc) 
Tapped Density 
(gm/cc) 
% Compressibility 
(%) 
Hausner’s Ratio Angle of repose 
SSD-S1 0.424±0.057 0.510±0.034 16.86±0.31 1.20±0.031 25.02±0.71 
SSD-S2 0.404±0.048 0.474±0.046 14.76±0.47 1.17±0.074 23.12±0.58 
SSD-S3 0.466±0.055 0.556±0.025 16.18±0.52 1.191±0.057 24.27±0.92 
SSD-S4 0.480±0.043 0.610±0.047 21.31±0.58 1.27±0.048 24.78±0.83 
SSD-S5 0.502±0.040 0.631±0.043 20.44±0.49 1.25±0.038 25.32±1.61 
SSD-C1 0.448±0.039 0.533±0.051 15.94±0.73 1.09±0.052 27.59±0.48 
SSD-C2 0.525±0.071 0.651±0.058 19.35±0.47 1.24±0.073 27.98±1.39 
SSD-C3 0.488±0.045 0.627±0.063 22.16±0.45 1.28±0.068 27.11±0.75 
SSD-C4 0.556±0.061 0.699±0.081 20.45±0.53 1.25±0.046 27.32±0.69 
SSD-C5 0.410±0.068 0.515±0.042 20.38±0.74 1.25±0.062 25.20±0.64 
SSD-P1 0.485±0.028 0.579±0.025 16.23±0.59 1.19±0.047 26.28±0.86 
SSD-P2 0.496±0.055 0.556±0.047 10.79±0.38 1.12±0.041 23.43±1.24 
SSD-P3 0.499±0.037 0.583±0.062 14.40±0.56 1.16±0.073 27.85±0.65 
SSD-P4 0.440±0.025 0.521±0.048 15.54±0.44 1.18±0.061 27.16±1.47 
SSD-P5 0.476±0.058 0.581±0.037 18.07±0.48 1.22±0.027 26.84±0.52 
*All values are expressed as Mean ± SD, n=3 
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Table 5: Result of Precompression parameter of immediate release and floating sustained release blend of Nifedipine 
Batch 
Code 
Parameters 
Bulk Density 
(gm/cc) 
Tapped Density 
(gm/cc) 
% Compressibility 
(%) 
Hausner’s Ratio Angle of repose 
IR 0.612 ±0.008 0.7062±  0.007 13.62 ±0.0019 1.15 ±0.0025 25.64± 1.18 
SR1 0.6234±0.031 0.710±0.044 12.19±0.063 1.14±0.04 26.61±0.56 
SR2 0.6023±0.053 0.7134±0.047 15.57±0.057 1.184±0.037 27.51±0.72 
SR3 0.598±0.047 0.701±0.07 14.69±0.032 1.004±0.032 24.70±0.61 
SR4 0.624±0.034 0.731±0.047 14.63±0.039 1.17±0.036 26.56±0.52 
SR5 0.614±0.046 0.698±0.062 12.09±0.028 1.13±0.044 24.70±0.54 
SR6 0.601±0.062 0.710±0.043 15.35±0.038 1.18±0.026 25.17±0.67 
SR7 0.615±0.046 0.720±0.058 14.58±0.052 1.17±0.048 25.45±0.75 
SR8 0.6162±0.037 0.7312±0.036 15.72±0.064 1.18±0.063 26.10±0.68 
SR9 0.598±0.057 0.678±0.065 11.79±0.049 1.13±0.048 28.22±0.59 
Table No.6: Result of Tablet properties of Bilayer Floating tablet formulation. 
 
Figure 1: Comparative drug release profile of bilayer tablet of Nifedipine 
 
*All values are expressed as Mean ±SD, n = 3 
            From the dissolution profile of the Bilayer tablet formulation (F1-F9) as shown in the Table No 6, from the figure 
No. 1 it was concluded that F5 batch was considered to be optimized formula, as it had highest percentage drug release of 
97.47% of all formulations. Formulation showed drug release up to 12hours. Its hardness was optimum, disintegration time 
24sec, floating lag time was 61sec. The reason for this could be the use of HPMC K100M & K15M in adequate proportion 
Sr. 
No 
Parameters 
Formulations Code & Results 
F1 F2 F3 F4 F5 F6 F7 F8 F9 
1 
Average 
Weight 
(360mg) 
361±0.06 363±0.08 359±0.05 360±0.05 361±0.06 360±0.06 359±0.05 360±0.06 361±0.07 
2 
Thickness 
(mm) 
3.02±0.03 3.05±0.04 3.01±0.02 3.01±0.06 3.02±0.01 3.04±0.03 3.07±0.05 3.03±0.03 3.02±0.06 
3 
Hardness 
(kg/cm2) 
6.4±0.5 5.4±0.4 5.4±0.2 6.8±0.2 5.8±0.4 5.0±0.4 7.0±0.5 5.2±0.4 5.2±0.7 
4 
Friability 
(%) 
0.078±0.035 0.071±0.041 0.082±0.032 0.069±0.048 0.062±0.039 0.092±0.023 0.096±0.028 0.083±0.02 0.06±0.049 
5 
DT  of  IR 
layer (Sec) 
25±0.82 31±0.23 24±0.27 27±0.75 24±0.17 28±0.37 29±0.47 26±0.33 31±0.12 
6 
% Swelling 
Index of SR 
later tablet 
61.2±0.47 64.9±0.58 74.3±0.81 58.4±0.51 82.8±0.36 80.4±0.15 54.2±0.093 70.8±0.39 76.5±0.48 
7 
Drug 
Content (%) 
96.3±0.9 97.5±0.5 96.1±0.3 96.7±0.3 98.3±0.8 97.5±0.1 98.2±0.4 98.7±0.9 97.5±0.2 
8 
Floating lag 
time (Sec) 
110±2.1 65±2.5 82±1.3 80±1.6 61±2.5 78±1.8 69±2.7 98±2.9 112±1.3 
9 
Floating 
time  (hrs) 
12.8±0.05 12.3±0.7 12±0.03 12.7± 0.09 12.6±0.05 12.4±0.04 12.6±0.06 13.1±0.03 12.4±0.06 
International Journal of Advances in Pharmaceutics 5 (5) 2016                                                                                 122 
 
 
with gas generating agent. HPMC K100M & HPMC K15M showed good swelling property due to which drug release in 
sustained manner. 
4.1 Evaluation of Dependent Variables and Mathematical Modeling: 
The values of dependent variables of bilayer tablet formulations are described in Table no.7. These values are 
necessary to get polynomial equations from Design Expert software for the respective dependent variable. 
Table 7: Experimental Runs and Observed Responses for 3
2
Factorial Design 
Batch 
Code Hardness  
Kg/cm
2
  (Y1) 
% Drug release (Y2) 
% Swelling 
(Y3) X1 X2 
F1 +1 -1 6.4 ± 0.5 82.39 ± 0.61 61.2±0.48 
F2 0 0 5.4 ±0.4 86.83 ±0.33 64.9±0.74 
F3 -1 +1 5.4 ±0.2 91.92 ±0.51 74.3±0.63 
F4 +1 0 6.8 ±0.2 81.35 ±0.57 58.4±0.86 
F5 0 +1 5.8 ±0.4 97.47 ±0.42 82.8±0.92 
F6 -1 -1 5.0 ±0.4 93.95 ±0.56 80.4±0.73 
F7 +1 +1 7.0 ±0.5 72.12 ±0.33 54.2±0.58 
F8 0 -1 5.2 ±0.4 89.74 ±0.71 70.8±0.62 
F9 -1 0 5.2 ±0.7 92.0   ± 0.47 76.5±0.57 
Table 8: Variable in 3
2 
factorial Design 
Independent Variables Coded Levels 
-1 0 +1 
 Actual Levels 
X1= HPMC K100M 60 80 100 
X2= HPMC K15M 10 20 30 
                                                 Response variable 
Y1=  Hardness  
Y2= % Drug release 
Y3= %  Swelling 
Table 9: Multiple Regression Output for Dependent Variables 
  Coefficient Hardness % Drug release % Swelling 
β0 5.47 87.53 69.28 
β1 0.77 -7.00 -9.57 
β2 0.27 -0.76 -0.18 
β11 0.50 - - 
β22 0.000 - - 
β12 0.050 - - 
r
2 0.9963 0.6115 0.6729 
p value(probe>F) 0.0008 0.0224 0.0350 
1. Probe >F less than 0.0500 indicate model term are significant. 
2.  R2 value less than 1.00 show model terms are significant.    
          4.1.1 Response 1: Hardness of Tablet  
For Hardness of tablet, following equation was obtained from design model, 
Y1=5.47+0.77X1+0.27X2+0.50X1
2
+0.0000X2
2
+0.050X 1X2 
Positive coefficient of X1 indicated increase in hardness of tablet with increase in HPMC K100M, positive 
coefficient of X2 indicated increase in response of Y1 i.e. increase in hardness  with increase in HPMC K15M. In 
combination it gives positive coefficient effect but less as compared to individual effect. The equation obtained was 
Quadratic equation. 
Surface response plot for Hardness of tablet showed that HPMC K100M (X1) effect was significant on hardness of 
tablet. As the concentration of HPMC K100M increases from 60-100   (-1 to +1) increase in hardness. HPMC K15M (X2) 
shows positive effect on hardness. As the concentration HPMC K15M increases from 10-30 then increase in hardness of 
tablet. 
4.1.2 Response 2: Percent drug release 
For Percent drug release, following equation was obtained from design model, 
Y2= 87.53 - 7.00X1 – 0.76X2 
Negative coefficient of X1 indicated decrease in % Drug release with increase in HPMC K100M, in the same way 
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negative coefficient of X2  indicate decrease in (Y2) i.e. % Drug release  with increase in HPMC K15M concentration. 
87.53 is the mean response i.e. mean % drug release from tablet. 
Surface responses plot for % Drug release shows that HPMC K100M (X1) effect was negative on % drug release. 
As the concentration of HPMC K100M increases from (-1 to +1) i.e. from 60-100 decrease in percent drug release. HPMC 
K15M also shows negative effect on response Y2. As we increase the HPMC K15M concentration from 10-30 decrease in 
% drug release but in slight extend. 
4.1.3 Response 3: Swelling Index:        Y3 = 69.28 - 9.57X1 – 0.18X2 
Negative coefficient of X1 indicated decrease in % Swelling with increase in HPMC K100M, in the same way 
negative coefficient of X2  indicate decrease in (Y2) i.e. % Swelling  with increase in HPMC K15M concentration. 69.28 is 
the mean response i.e. mean swelling index of tablet. 
Surface responses plot for % Swelling shows that HPMC K100M (X1) effect was negative on % swelling. As the 
concentration of HPMC K100M increases from (-1 to +1) i.e. from 60-100 decrease in percent swelling. HPMC K15M also 
shows negative effect on response Y2. As we increase the HPMC K15M concentration from 10-30 decrease in % swelling 
but in slight extend. 
 
a) Hardness 
 
b) % Drug release 
 
c) Swelling Index 
Figure 2: Response surface plot showing effect of factorial variables on a) Hardness of tablet   b) % Drug release c) 
Swelling Index 
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Putting all this responses result & after setting goal “seven” solutions were obtained from 9 combinations of 
categoric factor levels as shown in Table No.9. The best result was shown by the HPMC K100M at 80mg & HPMC K15M 
at 30mg concentration i.e. F5 batch having highest desirability 0.911.  
Table 10: Solutions for 9 combinations of categoric factor levels 
Sr. No HPMC K100M HPMC K15M 
Hardness 
Kg/cm2 
% Drug 
release 
Swelling 
Index (%) 
Desirability 
1 80 30 5.8 97.47 82.83 0.911 
2 60 30 5.4 91.92 77.06 0.712 
3 60 20 5.2 92 77.06 0.647 
4 80 10 5.2 89.74 72.83 0.576 
5 80 20 5.4 86.83 72.83 0.559 
6 100 10 6.4 82.39 57.93 0.364 
7 100 20 6.8 81.35 57.93 0.289 
From result of Optimization study and the result of various evaluation test like Hardness, Disintegration time, 
Floating lag time, Total floating time, % drug release, % Swelling it was found that formulation F5 show best result so it 
was optimize formulation. Formulation F5 then used for further evaluation parameter of tablet. 
4.2 FITR study of Bilayer Floating Tablet:- 
  FTIR study of Bilayer Floating Tablet of optimized batch of Nifedipine in comparison with Pure drug (Nifedipine) 
was done. The result of study is shown in following figure- 
 
Figure 3:  FTIR of Optimize formulation in comparison with Nifedipine 
4.3 Differential Scanning Calorimetry study for Final optimized Formulation:-  
  DSC study for Optimized batch of Bilayer floating Tablet of Nifedipine was done and the result is shown in 
following figure. 
 
Figure 4:  Comparative DSC study of Nifedipine with Surface solid dispersion & Optimized formulation 
 
4.4 Result of stability studies 
               After storage the formulation was analyzed for various physical parameters, results shown in Table 11.  No 
major differences were found between evaluated parameters before and after ageing / storage and all were in acceptable 
limits. 
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Table 11:  Evaluation parameters of stability batch 
Evaluation Parameters 
Before stability 
storage  (25±2 ̊c 
& 60±5%RH) 
After 
10 Days 
After 
20 days 
After 
30 days 
Temperature 40±2 ̊C & 75 ± 5 % RH 
Hardness(kg/cm
2
) 5.8±0.4 NC NC NC 
% Friability 0.062±0.039 NC NC NC 
Average Weight (mg) 361±0.06 NC NC NC 
Drug content    (%)           98.3±0.8 98.7±0.4 98.4±0.5 98.6±0.2 
Disintegration time  (sec)                                                 24±0.17 27±0.23 26±0.14 27±0.37 
Drug release (%)         97.47±0.42 97.20±0.48 97.60±0.33 97.23±035 
Swelling Index (%)                                        82.8±0.36 82.7±0.76 81.5±0.58 81.9±0.28 
Floating lag time (sec) 61±2.5 64±1.2 64±0.9 67±1.3 
Total floating time (hrs) 12.6±0.05 12.6±0.07 12.5±0.07 12.6±0.08 
The data are presented as mean value ± S.D 
 (n = 3) 
 NC- No Change. 
 
5. Conclusion 
Nifedipine is Calcium channel blocker fall under BCS class II (Low solubility & High permeability).  Nifedipine 
is rapidly absorbed with a time to maximum concentration (Tmax) of approximately 30 minutes following oral 
administration of capsule, immediate release tablet.  
Nifedipine has Low Solubility, Low Bioavailability (45-56%) and Low Half life (2hr). Frequent dosing of 
conventional dosage form Nifedipine is required to attain therapeutic level.  
To overcome the solubility problem surface solid dispersion was prepared by Sodium starch glycolate, 
Croscarmellose sodium & Crospovidone as polymer. The optimized batch is used for further preparation of bilayer tablet of 
Nifedipine in which one layer is Immediate release act as loading dose as well as for patient comfort & second layer 
(sustain release floating layer) which enables the prolong and continuous input of the drug to the gastro intestinal tract and 
improve the bioavailability of the medication.  
Sustained release floating layer prepared by HPMC K100M & HPMC K15M & Carbopol 934 P as a controlled 
release agent, sodium bicarbonate & citric acid act as effervescent agent.  
The identity of drug was confirmed by physical characteristics, spectrophotometric analysis such as UV 
spectrophotometric and FTIR and thermal behaviour by DSC. Bilayer tablet prepared by direct compression technique. 
Optimization of Bilayer floating formulations carried out using 3
2
 Factorial designs. Two independent variables X1 (conc. 
of HPMC K100M) and X2 (conc. of HPMC K15M) for floating sustained release tablets was selected and then prepared 
nine batches of bilayer tablets.  
From the results of dependent variables (Responses) like Hardness, Swelling index, % drug release and from result 
of evaluations of bilayer formulations like Floating lag time, Total floating time, Disintegration time etc of nine batches F5 
was selected as optimized batch. 
The optimized formulation was then use for FTIR & DSC study for determination of interaction & stability of 
formulation. Then comparison of final bilayer formulation with marketed formulation was done. Then stability study as per 
ICH guideline was done at 40°c± 2°c & 75% ±5% RH condition. 
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